Ogivri 83257-0003
Generic: Trastuzumab-Dkst
Product NDC
83257-0003- Manufacturer
- Biocon Biologics Inc.
- Dosage Form
- Injection, Powder, Lyophilized, For Solution
- Route
- Intravenous
- Product Type
- Human Prescription Drug
- Marketing Start
- October 1, 2023
- Listing Expires
- December 31, 2026
- Application
- BLA761074
Need to source Ogivri? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Trastuzumab | 420 mg/20mL |
Drug Class
HER2/neu Receptor Antagonist [EPC]HER2/Neu/cerbB2 Antagonists [MoA]HER2/neu Receptor Antagonist [EPC]